1,2-distearoyllecithin has been researched along with ovalbumin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| André, C; Barratt, G; Devissaguet, JP; Genin, I; Ouadahi, S; Paternostre, M; Puisieux, F; Thao, TX | 1 |
| Asai, T; Ichikawa, K; Miyauchi, H; Oku, N; Shimizu, K; Urakami, T; Yonezawa, S | 1 |
| Kadowaki, N; Kodama, T; Maruyama, K; Namai, E; Oda, Y; Okada, N; Suzuki, R; Tachibana, K; Taira, Y; Utoguchi, N | 1 |
| Asai, T; Ichikawa, K; Ishida, T; Kawashima, H; Kiwada, H; Miyauchi, H; Oku, N; Shimizu, K; Urakami, T; Yonezawa, S | 1 |
| Foged, C; Ingvarsson, PT; Irlik, PJ; Nielsen, HM; Rasmussen, IS; Viaene, M | 1 |
| Duru, C; Forbes, N; Hussain, MT; Malik, KP; Matejtschuk, P; Perrie, Y | 1 |
6 other study(ies) available for 1,2-distearoyllecithin and ovalbumin
| Article | Year |
|---|---|
Liposomal formulations for oral immunotherapy: in-vitro stability in synthetic intestinal media and in-vivo efficacy in the mouse.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Desensitization, Immunologic; Drug Carriers; Female; Immunoblotting; Immunoglobulin E; Liposomes; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphatidylcholines | 1998 |
Enhanced desensitization efficacy by liposomal conjugation of a specific antigen.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens; Cholesterol; Desensitization, Immunologic; Dose-Response Relationship, Immunologic; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Hypersensitivity; Immunoglobulin E; Immunoglobulin G; Liposomes; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphatidylcholines; Spleen; Tissue Distribution | 2007 |
A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy.
Topics: Animals; Antigen Presentation; Antigens; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Cytotoxicity Tests, Immunologic; Dendritic Cells; Endocytosis; Fluorocarbons; Immunotherapy, Active; Interleukin-2; Liposomes; Mice; Mice, Inbred C57BL; Neoplasms; Ovalbumin; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Sodium Azide; Survival Analysis; T-Lymphocytes, Cytotoxic; Ultrasonics | 2009 |
Suppression of immune response by antigen-modified liposomes encapsulating model agents: a novel strategy for the treatment of allergy.
Topics: Animals; Antibiotics, Antineoplastic; Antigens; Cholesterol; Doxorubicin; Female; Hypersensitivity; Immunoglobulin E; Immunoglobulin G; Kidney; Liposomes; Liver; Lung; Mice; Mice, Inbred BALB C; Myocardium; Ovalbumin; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Spleen | 2013 |
The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Cations; Cell Line, Tumor; Cell Survival; Epithelial Cells; Glycolipids; Humans; Lipids; Liposomes; Lung; Mucus; Ovalbumin; Phosphatidylcholines; Quaternary Ammonium Compounds; Respiratory Mucosa; Vaccines | 2014 |
Freeze-drying cycle optimization for the rapid preservation of protein-loaded liposomal formulations.
Topics: Cholesterol; Dimyristoylphosphatidylcholine; Drug Delivery Systems; Fatty Acids, Monounsaturated; Freeze Drying; High-Throughput Screening Assays; Liposomes; Microfluidics; Ovalbumin; Phosphatidylcholines; Proteins; Quaternary Ammonium Compounds; Technology, Pharmaceutical | 2020 |